|
|
|
Pharmaceutical companies must do more to mitigate the growing legal and environmental, social, and governance (ESG) risks around anti-microbial resistance. Experts at international law firm Freshfields offer tips for company leaders. |
|
|
|
Ono Pharmaceuticals continues its quest to become a global biopharmaceutical company, after discovering and helping to launch one of the most successful cancer drugs, Opdivo, in the last decade. |
|
|
|
|
|
| Integrated Solutions For Advanced Therapies | The right CDMO offering integrated services can ease common CGT manufacturing problems such as scale, access to high-demand raw material, viral vector production, and quality requirements. |
|
|
|
| Navigating AAV Vector Manufacturing | Due to its therapeutic impact on a wide range of diseases and disorders, adeno-associated virus (AAV) gene therapy is one of the most promising advances in modern medicine. |
|
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
Connect With Life Science Leader: |
|
|
|